AustralieFrV1, PubMed, Checkpoint, bibRecord, 001932

Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis.

Identifieur interne : 001932 ( PubMed/Checkpoint ); précédent : 001931; suivant : 001933

Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis.

Auteurs : Cédric Benoist D'Azy [France] ; Bruno Pereira [France] ; Frédéric Chiambaretta [France] ; Frédéric Dutheil [France]

Source :

PloS one [ 1932-6203 ] ; 2016.

RBID : pubmed:27907028

Descripteurs français

KwdFr :
- Adulte d'âge moyen, Femelle, Glaucome à angle fermé (anatomopathologie), Glaucome à angle fermé (diagnostic), Glaucome à angle fermé (métabolisme), Glaucome à angle ouvert (anatomopathologie), Glaucome à angle ouvert (diagnostic), Glaucome à angle ouvert (métabolisme), Glutathione peroxidase (métabolisme), Humains, Humeur aqueuse (), Humeur aqueuse (métabolisme), Maladie chronique, Malonaldéhyde (métabolisme), Marqueurs biologiques (métabolisme), Mâle, Stress oxydatif, Sujet âgé, Superoxide dismutase (métabolisme), Études cas-témoins.
MESH :
- anatomopathologie : Glaucome à angle fermé, Glaucome à angle ouvert.
- diagnostic : Glaucome à angle fermé, Glaucome à angle ouvert.
- métabolisme : Glaucome à angle fermé, Glaucome à angle ouvert, Glutathione peroxidase, Humeur aqueuse, Malonaldéhyde, Marqueurs biologiques, Superoxide dismutase.
- Adulte d'âge moyen, Femelle, Humains, Humeur aqueuse, Maladie chronique, Mâle, Stress oxydatif, Sujet âgé, Études cas-témoins.

English descriptors

KwdEn :
- Aged, Aqueous Humor (chemistry), Aqueous Humor (metabolism), Biomarkers (metabolism), Case-Control Studies, Chronic Disease, Female, Glaucoma, Angle-Closure (diagnosis), Glaucoma, Angle-Closure (metabolism), Glaucoma, Angle-Closure (pathology), Glaucoma, Open-Angle (diagnosis), Glaucoma, Open-Angle (metabolism), Glaucoma, Open-Angle (pathology), Glutathione Peroxidase (metabolism), Humans, Male, Malondialdehyde (metabolism), Middle Aged, Oxidative Stress, Superoxide Dismutase (metabolism).
MESH :
- chemical , metabolism : Biomarkers, Glutathione Peroxidase, Malondialdehyde, Superoxide Dismutase.
- chemistry : Aqueous Humor.
- diagnosis : Glaucoma, Angle-Closure, Glaucoma, Open-Angle.
- metabolism : Aqueous Humor, Glaucoma, Angle-Closure, Glaucoma, Open-Angle.
- pathology : Glaucoma, Angle-Closure, Glaucoma, Open-Angle.
- Aged, Case-Control Studies, Chronic Disease, Female, Humans, Male, Middle Aged, Oxidative Stress.

Abstract

Chronic glaucoma is a multifactorial disease among which oxidative stress may play a major pathophysiological role. We conducted a systematic review and meta-analysis to evaluate the levels of oxidative and antioxidative stress markers in chronic glaucoma compared with a control group. The PubMed, Cochrane Library, Embase and Science Direct databases were searched for studies reporting oxidative and antioxidative stress markers in chronic glaucoma and in healthy controls using the following keywords: "oxidative stress" or "oxidant stress" or "nitrative stress" or "oxidative damage" or "nitrative damage" or "antioxidative stress" or "antioxidant stress" or "antinitrative stress" and "glaucoma". We stratified our meta-analysis on the type of biomarkers, the type of glaucoma, and the origin of the sample (serum or aqueous humor). We included 22 case-control studies with a total of 2913 patients: 1614 with glaucoma and 1319 healthy controls. We included 12 studies in the meta-analysis on oxidative stress markers and 19 on antioxidative stress markers. We demonstrated an overall increase in oxidative stress markers in glaucoma (effect size = 1.64; 95%CI 1.20-2.09), ranging from an effect size of 1.29 in serum (95%CI 0.84-1.74) to 2.62 in aqueous humor (95%CI 1.60-3.65). Despite a decrease in antioxidative stress marker in serum (effect size = -0.41; 95%CI -0.72 to -0.11), some increased in aqueous humor (superoxide dismutase, effect size = 3.53; 95%CI 1.20-5.85 and glutathione peroxidase, effect size = 6.60; 95%CI 3.88-9.31). The differences in the serum levels of oxidative stress markers between glaucoma patients and controls were significantly higher in primary open angle glaucoma vs primary angle closed glaucoma (effect size = 12.7; 95%CI 8.78-16.6, P < 0.001), and higher in pseudo-exfoliative glaucoma vs primary angle closed glaucoma (effect size = 12.2; 95%CI 8.96-15.5, P < 0.001). In conclusion, oxidative stress increased in glaucoma, both in serum and aqueous humor. Malonyldialdehyde seemed the best biomarkers of oxidative stress in serum. The increase of some antioxidant markers could be a protective response of the eye against oxidative stress.

DOI: 10.1371/journal.pone.0166915
PubMed: 27907028

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001496
to stream PubMed, to step Curation: 001474

Links to Exploration step

pubmed:27907028

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis.</title>
<author><name sortKey="Benoist D Azy, Cedric" sort="Benoist D Azy, Cedric" uniqKey="Benoist D Azy C" first="Cédric" last="Benoist D'Azy">Cédric Benoist D'Azy</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pereira, Bruno" sort="Pereira, Bruno" uniqKey="Pereira B" first="Bruno" last="Pereira">Bruno Pereira</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital of Clermont-Ferrand (CHU), Clinical Research Direction, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Clermont-Ferrand (CHU), Clinical Research Direction, Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chiambaretta, Frederic" sort="Chiambaretta, Frederic" uniqKey="Chiambaretta F" first="Frédéric" last="Chiambaretta">Frédéric Chiambaretta</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dutheil, Frederic" sort="Dutheil, Frederic" uniqKey="Dutheil F" first="Frédéric" last="Dutheil">Frédéric Dutheil</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27907028</idno>
<idno type="pmid">27907028</idno>
<idno type="doi">10.1371/journal.pone.0166915</idno>
<idno type="wicri:Area/PubMed/Corpus">001496</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001496</idno>
<idno type="wicri:Area/PubMed/Curation">001474</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001474</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001474</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001474</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis.</title>
<author><name sortKey="Benoist D Azy, Cedric" sort="Benoist D Azy, Cedric" uniqKey="Benoist D Azy C" first="Cédric" last="Benoist D'Azy">Cédric Benoist D'Azy</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pereira, Bruno" sort="Pereira, Bruno" uniqKey="Pereira B" first="Bruno" last="Pereira">Bruno Pereira</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital of Clermont-Ferrand (CHU), Clinical Research Direction, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Clermont-Ferrand (CHU), Clinical Research Direction, Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chiambaretta, Frederic" sort="Chiambaretta, Frederic" uniqKey="Chiambaretta F" first="Frédéric" last="Chiambaretta">Frédéric Chiambaretta</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dutheil, Frederic" sort="Dutheil, Frederic" uniqKey="Dutheil F" first="Frédéric" last="Dutheil">Frédéric Dutheil</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aqueous Humor (chemistry)</term>
<term>Aqueous Humor (metabolism)</term>
<term>Biomarkers (metabolism)</term>
<term>Case-Control Studies</term>
<term>Chronic Disease</term>
<term>Female</term>
<term>Glaucoma, Angle-Closure (diagnosis)</term>
<term>Glaucoma, Angle-Closure (metabolism)</term>
<term>Glaucoma, Angle-Closure (pathology)</term>
<term>Glaucoma, Open-Angle (diagnosis)</term>
<term>Glaucoma, Open-Angle (metabolism)</term>
<term>Glaucoma, Open-Angle (pathology)</term>
<term>Glutathione Peroxidase (metabolism)</term>
<term>Humans</term>
<term>Male</term>
<term>Malondialdehyde (metabolism)</term>
<term>Middle Aged</term>
<term>Oxidative Stress</term>
<term>Superoxide Dismutase (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Glaucome à angle fermé (anatomopathologie)</term>
<term>Glaucome à angle fermé (diagnostic)</term>
<term>Glaucome à angle fermé (métabolisme)</term>
<term>Glaucome à angle ouvert (anatomopathologie)</term>
<term>Glaucome à angle ouvert (diagnostic)</term>
<term>Glaucome à angle ouvert (métabolisme)</term>
<term>Glutathione peroxidase (métabolisme)</term>
<term>Humains</term>
<term>Humeur aqueuse ()</term>
<term>Humeur aqueuse (métabolisme)</term>
<term>Maladie chronique</term>
<term>Malonaldéhyde (métabolisme)</term>
<term>Marqueurs biologiques (métabolisme)</term>
<term>Mâle</term>
<term>Stress oxydatif</term>
<term>Sujet âgé</term>
<term>Superoxide dismutase (métabolisme)</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Biomarkers</term>
<term>Glutathione Peroxidase</term>
<term>Malondialdehyde</term>
<term>Superoxide Dismutase</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Glaucome à angle fermé</term>
<term>Glaucome à angle ouvert</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Aqueous Humor</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Glaucoma, Angle-Closure</term>
<term>Glaucoma, Open-Angle</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Glaucome à angle fermé</term>
<term>Glaucome à angle ouvert</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Aqueous Humor</term>
<term>Glaucoma, Angle-Closure</term>
<term>Glaucoma, Open-Angle</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Glaucome à angle fermé</term>
<term>Glaucome à angle ouvert</term>
<term>Glutathione peroxidase</term>
<term>Humeur aqueuse</term>
<term>Malonaldéhyde</term>
<term>Marqueurs biologiques</term>
<term>Superoxide dismutase</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Glaucoma, Angle-Closure</term>
<term>Glaucoma, Open-Angle</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Case-Control Studies</term>
<term>Chronic Disease</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Humeur aqueuse</term>
<term>Maladie chronique</term>
<term>Mâle</term>
<term>Stress oxydatif</term>
<term>Sujet âgé</term>
<term>Études cas-témoins</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Chronic glaucoma is a multifactorial disease among which oxidative stress may play a major pathophysiological role. We conducted a systematic review and meta-analysis to evaluate the levels of oxidative and antioxidative stress markers in chronic glaucoma compared with a control group. The PubMed, Cochrane Library, Embase and Science Direct databases were searched for studies reporting oxidative and antioxidative stress markers in chronic glaucoma and in healthy controls using the following keywords: "oxidative stress" or "oxidant stress" or "nitrative stress" or "oxidative damage" or "nitrative damage" or "antioxidative stress" or "antioxidant stress" or "antinitrative stress" and "glaucoma". We stratified our meta-analysis on the type of biomarkers, the type of glaucoma, and the origin of the sample (serum or aqueous humor). We included 22 case-control studies with a total of 2913 patients: 1614 with glaucoma and 1319 healthy controls. We included 12 studies in the meta-analysis on oxidative stress markers and 19 on antioxidative stress markers. We demonstrated an overall increase in oxidative stress markers in glaucoma (effect size = 1.64; 95%CI 1.20-2.09), ranging from an effect size of 1.29 in serum (95%CI 0.84-1.74) to 2.62 in aqueous humor (95%CI 1.60-3.65). Despite a decrease in antioxidative stress marker in serum (effect size = -0.41; 95%CI -0.72 to -0.11), some increased in aqueous humor (superoxide dismutase, effect size = 3.53; 95%CI 1.20-5.85 and glutathione peroxidase, effect size = 6.60; 95%CI 3.88-9.31). The differences in the serum levels of oxidative stress markers between glaucoma patients and controls were significantly higher in primary open angle glaucoma vs primary angle closed glaucoma (effect size = 12.7; 95%CI 8.78-16.6, P < 0.001), and higher in pseudo-exfoliative glaucoma vs primary angle closed glaucoma (effect size = 12.2; 95%CI 8.96-15.5, P < 0.001). In conclusion, oxidative stress increased in glaucoma, both in serum and aqueous humor. Malonyldialdehyde seemed the best biomarkers of oxidative stress in serum. The increase of some antioxidant markers could be a protective response of the eye against oxidative stress.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27907028</PMID>
<DateCreated><Year>2016</Year>
<Month>12</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>06</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>11</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>11</Volume>
<Issue>12</Issue>
<PubDate><Year>2016</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis.</ArticleTitle>
<Pagination><MedlinePgn>e0166915</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0166915</ELocationID>
<Abstract><AbstractText>Chronic glaucoma is a multifactorial disease among which oxidative stress may play a major pathophysiological role. We conducted a systematic review and meta-analysis to evaluate the levels of oxidative and antioxidative stress markers in chronic glaucoma compared with a control group. The PubMed, Cochrane Library, Embase and Science Direct databases were searched for studies reporting oxidative and antioxidative stress markers in chronic glaucoma and in healthy controls using the following keywords: "oxidative stress" or "oxidant stress" or "nitrative stress" or "oxidative damage" or "nitrative damage" or "antioxidative stress" or "antioxidant stress" or "antinitrative stress" and "glaucoma". We stratified our meta-analysis on the type of biomarkers, the type of glaucoma, and the origin of the sample (serum or aqueous humor). We included 22 case-control studies with a total of 2913 patients: 1614 with glaucoma and 1319 healthy controls. We included 12 studies in the meta-analysis on oxidative stress markers and 19 on antioxidative stress markers. We demonstrated an overall increase in oxidative stress markers in glaucoma (effect size = 1.64; 95%CI 1.20-2.09), ranging from an effect size of 1.29 in serum (95%CI 0.84-1.74) to 2.62 in aqueous humor (95%CI 1.60-3.65). Despite a decrease in antioxidative stress marker in serum (effect size = -0.41; 95%CI -0.72 to -0.11), some increased in aqueous humor (superoxide dismutase, effect size = 3.53; 95%CI 1.20-5.85 and glutathione peroxidase, effect size = 6.60; 95%CI 3.88-9.31). The differences in the serum levels of oxidative stress markers between glaucoma patients and controls were significantly higher in primary open angle glaucoma vs primary angle closed glaucoma (effect size = 12.7; 95%CI 8.78-16.6, P < 0.001), and higher in pseudo-exfoliative glaucoma vs primary angle closed glaucoma (effect size = 12.2; 95%CI 8.96-15.5, P < 0.001). In conclusion, oxidative stress increased in glaucoma, both in serum and aqueous humor. Malonyldialdehyde seemed the best biomarkers of oxidative stress in serum. The increase of some antioxidant markers could be a protective response of the eye against oxidative stress.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benoist d'Azy</LastName>
<ForeName>Cédric</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pereira</LastName>
<ForeName>Bruno</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>University Hospital of Clermont-Ferrand (CHU), Clinical Research Direction, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chiambaretta</LastName>
<ForeName>Frédéric</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dutheil</LastName>
<ForeName>Frédéric</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-1468-6029</Identifier>
<AffiliationInfo><Affiliation>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>CNRS Physiological and Psychosocial Stress, LAPSCO, University Clermont Auvergne, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Australian Catholic University, Faculty of Health, School of Exercise Science, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University Clermont Auvergne, Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological conditions EA3533, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Research Centre in Human Nutrition (CRNH) Auvergne, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>12</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4Y8F71G49Q</RegistryNumber>
<NameOfSubstance UI="D008315">Malondialdehyde</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.11.1.9</RegistryNumber>
<NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber>
<NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C562750">Glaucoma, Primary Open Angle</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mini Rev Med Chem. 2015;16(3):241-57</RefSource>
<PMID Version="1">26586128</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterol Hepatol (N Y). 2007 Aug;3(8):637-42</RefSource>
<PMID Version="1">21960873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2015 Mar;230(3):510-25</RefSource>
<PMID Version="1">25216121</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3783-9</RefSource>
<PMID Version="1">12939292</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Ophthalmol. 2011 Sep-Oct;39(7):593-4</RefSource>
<PMID Version="1">22452677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2011;17:2769-75</RefSource>
<PMID Version="1">22065931</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Org Chem. 1975 Nov 28;40(24):3615-7</RefSource>
<PMID Version="1">1185332</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Ophthalmol. 2015 Oct 18;8(5):985-90</RefSource>
<PMID Version="1">26558214</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Glaucoma. 2016 Jun;25(6):505-9</RefSource>
<PMID Version="1">26766401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Ophthalmol. 2006 Mar;90(3):262-7</RefSource>
<PMID Version="1">16488940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Nutr. 2015 Apr 28;113(8):1182-94</RefSource>
<PMID Version="1">25919436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Lab. 2014;60(1):79-86</RefSource>
<PMID Version="1">24600979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 2014 Aug;39(8):823-9</RefSource>
<PMID Version="1">24912005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nutrition. 2014 Sep;30(9):986-91</RefSource>
<PMID Version="1">24976430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 2011 Aug;36(8):713-8</RefSource>
<PMID Version="1">21780920</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Middle East Afr J Ophthalmol. 2015 Oct-Dec;22(4):489-94</RefSource>
<PMID Version="1">26692723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1849-53</RefSource>
<PMID Version="1">8759353</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 2010 Apr;35(4):295-301</RefSource>
<PMID Version="1">20373896</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Redox Biol. 2015 ;4:226-33</RefSource>
<PMID Version="1">25617803</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Control Clin Trials. 1986 Sep;7(3):177-88</RefSource>
<PMID Version="1">3802833</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ophthalmologica. 2000 Jan-Feb;214(1):78-85</RefSource>
<PMID Version="1">10657746</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2011 Jan 07;17:41-6</RefSource>
<PMID Version="1">21245957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Glaucoma. 2007 May;16(3):334-43</RefSource>
<PMID Version="1">17438430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ Open. 2011 Feb 26;1(1):e000048</RefSource>
<PMID Version="1">22021739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 2013 Sep;38(9):959-64</RefSource>
<PMID Version="1">23651069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2008 Aug 15;45(4):367-76</RefSource>
<PMID Version="1">18489911</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(11):e49680</RefSource>
<PMID Version="1">23189153</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Ophthalmol. 2015 Sep;93(6):546-54</RefSource>
<PMID Version="1">25545196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Chest. 2014 Jun;145(6):1339-46</RefSource>
<PMID Version="1">24480869</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Res Notes. 2014 Mar 19;7:163</RefSource>
<PMID Version="1">24646376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Mol Med. 2016 Oct;38(4):995-1002</RefSource>
<PMID Version="1">27572245</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2007 Mar;84(3):389-99</RefSource>
<PMID Version="1">17196589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Jun 03;11(6):e0156431</RefSource>
<PMID Version="1">27257676</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Crit Rev Clin Lab Sci. 2009;46(5-6):241-81</RefSource>
<PMID Version="1">19958214</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oxid Med Cell Longev. 2016;2016:3164734</RefSource>
<PMID Version="1">26881021</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2010 Jul 09;16:1260-71</RefSource>
<PMID Version="1">20664701</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Sports Med. 2015 Sep;45(9):1285-94</RefSource>
<PMID Version="1">25946994</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2006 Mar;612(2):105-14</RefSource>
<PMID Version="1">16413223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Exp Mol Pathol. 2011 Apr;90(2):231-7</RefSource>
<PMID Version="1">21241689</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 1998 May;39(6):1053-8</RefSource>
<PMID Version="1">9579487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ Open. 2016 Jan 14;6(1):e009675</RefSource>
<PMID Version="1">26769784</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Aug;10(8):1343-74</RefSource>
<PMID Version="1">18522489</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2011 Oct;118(10):1989-1994.e2</RefSource>
<PMID Version="1">21684603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Clin Pract. 2014 May;68(5):533-4</RefSource>
<PMID Version="1">24750523</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ageing Res Rev. 2009 Jan;8(1):18-30</RefSource>
<PMID Version="1">18692159</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Hemorheol Microcirc. 2000;23(1):23-30</RefSource>
<PMID Version="1">11214710</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Ophthalmol. 2005 Nov;89(11):1500-5</RefSource>
<PMID Version="1">16234461</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(11):e27218</RefSource>
<PMID Version="1">22096540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Glaucoma. 2009 Dec;18(9):662-5</RefSource>
<PMID Version="1">20010244</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Glob Health. 2013 Dec;1(6):e339-49</RefSource>
<PMID Version="1">25104599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Ophthalmol. 2012 Oct;154(4):635-44</RefSource>
<PMID Version="1">22818906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biochem. 2014 Mar;388(1-2):173-83</RefSource>
<PMID Version="1">24311110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2015 Aug 06;6:e1839</RefSource>
<PMID Version="1">26247724</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA Ophthalmol. 2015 Aug;133(8):938-46</RefSource>
<PMID Version="1">26043441</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Glaucoma. 2008 Jun-Jul;17(4):263-8</RefSource>
<PMID Version="1">18552610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Ophthalmol. 2004 Jan;137(1):62-9</RefSource>
<PMID Version="1">14700645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Hemorheol Microcirc. 2016 Jan 27;62(4):369-78</RefSource>
<PMID Version="1">26890101</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eye (Lond). 2005 May;19(5):580-3</RefSource>
<PMID Version="1">15332106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2007 Oct 16;147(8):W163-94</RefSource>
<PMID Version="1">17938389</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Zhonghua Yan Ke Za Zhi. 2004 Nov;40(11):726-32</RefSource>
<PMID Version="1">15634477</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):246-53</RefSource>
<PMID Version="1">24552277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2012 Sep;69(18):2999-3013</RefSource>
<PMID Version="1">22446749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Gerontol A Biol Sci Med Sci. 2015 Apr;70(4):518-24</RefSource>
<PMID Version="1">25070660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Surv Ophthalmol. 2003 May-Jun;48(3):295-313</RefSource>
<PMID Version="1">12745004</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Saudi Med J. 2015 Jun;36(6):671-7</RefSource>
<PMID Version="1">25987108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>FASEB J. 1995 Sep;9(12):1173-82</RefSource>
<PMID Version="1">7672510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Biochem. 1995 Aug 15;232(1):188-91</RefSource>
<PMID Version="1">7556149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Graefes Arch Clin Exp Ophthalmol. 2011 Jun;249(6):895-901</RefSource>
<PMID Version="1">21234587</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2012 Oct;103:55-62</RefSource>
<PMID Version="1">22974818</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prog Brain Res. 2008;173:385-407</RefSource>
<PMID Version="1">18929123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Nutr Sci Vitaminol (Tokyo). 2014;60(3):194-205</RefSource>
<PMID Version="1">25078376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 1991;10(3-4):177-84</RefSource>
<PMID Version="1">1650736</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eye (Lond). 2013 Apr;27(4):487-94</RefSource>
<PMID Version="1">23429409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eye (Lond). 2009 Aug;23(8):1691-7</RefSource>
<PMID Version="1">19023334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prog Mol Biol Transl Sci. 2015;134:315-42</RefSource>
<PMID Version="1">26310163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eye (Lond). 2011 May;25(5):587-95</RefSource>
<PMID Version="1">21562585</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2013 Aug 07;19:1841-6</RefSource>
<PMID Version="1">23946639</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Pharmacol Physiol. 2007 Oct;34(10):1037-43</RefSource>
<PMID Version="1">17714091</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001082" MajorTopicYN="N">Aqueous Humor</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015812" MajorTopicYN="N">Glaucoma, Angle-Closure</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005979" MajorTopicYN="N">Glutathione Peroxidase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008315" MajorTopicYN="N">Malondialdehyde</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>07</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>11</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>12</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>6</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27907028</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0166915</ArticleId>
<ArticleId IdType="pii">PONE-D-16-28406</ArticleId>
<ArticleId IdType="pmc">PMC5131953</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Auvergne (région administrative)</li>
<li>Auvergne-Rhône-Alpes</li>
</region>
<settlement><li>Clermont-Ferrand</li>
</settlement>
</list>
<tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Benoist D Azy, Cedric" sort="Benoist D Azy, Cedric" uniqKey="Benoist D Azy C" first="Cédric" last="Benoist D'Azy">Cédric Benoist D'Azy</name>
</region>
<name sortKey="Chiambaretta, Frederic" sort="Chiambaretta, Frederic" uniqKey="Chiambaretta F" first="Frédéric" last="Chiambaretta">Frédéric Chiambaretta</name>
<name sortKey="Dutheil, Frederic" sort="Dutheil, Frederic" uniqKey="Dutheil F" first="Frédéric" last="Dutheil">Frédéric Dutheil</name>
<name sortKey="Pereira, Bruno" sort="Pereira, Bruno" uniqKey="Pereira B" first="Bruno" last="Pereira">Bruno Pereira</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001932 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001932 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:27907028
   |texte=   Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:27907028" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis.

Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki